BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15657375)

  • 1. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.
    Rotondi M; Falorni A; De Bellis A; Laureti S; Ferruzzi P; Romagnani P; Buonamano A; Lazzeri E; Crescioli C; Mannelli M; Santeusanio F; Bellastella A; Serio M
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2357-63. PubMed ID: 15657375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
    Antonelli A; Rotondi M; Ferrari SM; Fallahi P; Romagnani P; Franceschini SS; Serio M; Ferrannini E
    J Clin Endocrinol Metab; 2006 Feb; 91(2):614-20. PubMed ID: 16303841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ and tumor necrosis factor-α sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?
    Rotondi M; Coperchini F; Pignatti P; Sideri R; Groppelli G; Leporati P; La Manna L; Magri F; Mariotti S; Chiovato L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):308-13. PubMed ID: 23118425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.
    Rotondi M; Lazzeri E; Romagnani P; Serio M
    J Endocrinol Invest; 2003 Feb; 26(2):177-80. PubMed ID: 12739748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
    Antonelli A; Rotondi M; Fallahi P; Grosso M; Boni G; Ferrari SM; Romagnani P; Serio M; Mariani G; Ferrannini E
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1485-90. PubMed ID: 17244787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
    Kemp EH; Metcalfe RA; Smith KA; Woodroofe MN; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):207-13. PubMed ID: 12864798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.
    Bratland E; Hellesen A; Husebye ES
    Mol Cell Endocrinol; 2013 Jan; 365(1):75-83. PubMed ID: 22989785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Paolicchi A; Ferrannini E; Serio M
    Eur J Endocrinol; 2005 Feb; 152(2):171-7. PubMed ID: 15745922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Buonamano A; Ferrannini E; Serio M
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5496-9. PubMed ID: 15531503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.
    Edvardsen K; Bjånesøy T; Hellesen A; Breivik L; Bakke M; Husebye ES; Bratland E
    J Interferon Cytokine Res; 2015 Oct; 35(10):759-70. PubMed ID: 25978633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
    Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
    Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.
    García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin.
    Wulffraat NM; Drexhage HA; Bottazzo GF; Wiersinga WM; Jeucken P; Van der Gaag R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):231-8. PubMed ID: 2546959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of chemokines in endocrine autoimmune diseases.
    Rotondi M; Chiovato L; Romagnani S; Serio M; Romagnani P
    Endocr Rev; 2007 Aug; 28(5):492-520. PubMed ID: 17475924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
    Aggarwal A; Agarwal S; Misra R
    Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.